3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
1
Lymphoma, Follicular
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Interventions
etrolizumab
5
Infliximab
3
Adalimumab
2
peficitinib
1
golimumab
1
NX-13
1
Methylprednisolone
1
Mesalamine
1
Injections
1
CT-P13
1
Andrographis paniculata extract
1
ABX464
1
2-(3',4'-dihydroxyphenyl-1-azo)benzimidazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Colitis, Ulcerative
×
Mesalamine
×
Clear all
NCT02093663
2021-06-09
PACE
Takeda
Phase 3
Completed
107 enrolled
18 charts